BNP Paribas Financial Markets Has $628,000 Position in American Vanguard Co. (NYSE:AVD)

BNP Paribas Financial Markets raised its position in American Vanguard Co. (NYSE:AVD) by 99.6% during the third quarter, HoldingsChannel.com reports. The firm owned 118,492 shares of the basic materials company’s stock after buying an additional 59,128 shares during the quarter. BNP Paribas Financial Markets’ holdings in American Vanguard were worth $628,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Pullen Investment Management LLC increased its position in shares of American Vanguard by 2.4% during the second quarter. Pullen Investment Management LLC now owns 70,089 shares of the basic materials company’s stock valued at $603,000 after purchasing an additional 1,628 shares during the period. Empowered Funds LLC boosted its holdings in American Vanguard by 5.2% during the third quarter. Empowered Funds LLC now owns 64,915 shares of the basic materials company’s stock worth $344,000 after buying an additional 3,216 shares during the last quarter. Point72 DIFC Ltd lifted its holdings in American Vanguard by 195.7% during the second quarter. Point72 DIFC Ltd now owns 5,080 shares of the basic materials company’s stock worth $44,000 after acquiring an additional 3,362 shares in the last quarter. Gladius Capital Management LP acquired a new position in shares of American Vanguard in the second quarter valued at approximately $32,000. Finally, Nisa Investment Advisors LLC raised its position in American Vanguard by 7,554.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,210 shares of the basic materials company’s stock valued at $36,000 after buying an additional 4,155 shares during the last quarter. Institutional investors and hedge funds own 79.04% of the company’s stock.

American Vanguard Price Performance

Shares of NYSE AVD opened at $5.27 on Friday. The stock’s 50-day simple moving average is $5.63 and its two-hundred day simple moving average is $6.82. The firm has a market capitalization of $151.71 million, a P/E ratio of -5.12 and a beta of 0.89. American Vanguard Co. has a twelve month low of $4.95 and a twelve month high of $14.28. The company has a quick ratio of 0.79, a current ratio of 1.89 and a debt-to-equity ratio of 0.55.

Analyst Ratings Changes

Separately, StockNews.com raised American Vanguard from a “sell” rating to a “hold” rating in a research report on Wednesday, September 25th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, American Vanguard currently has an average rating of “Moderate Buy” and a consensus target price of $16.67.

Insider Activity at American Vanguard

In related news, Director Steven D. Macicek bought 12,000 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was acquired at an average cost of $5.97 per share, for a total transaction of $71,640.00. Following the purchase, the director now owns 31,218 shares in the company, valued at approximately $186,371.46. This represents a 62.44 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 10.10% of the stock is currently owned by company insiders.

American Vanguard Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.